GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
N

Nova Leap Health NLH.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.45

—

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$31.5m

FY2016FY2025

Net income

−$189,864

FY2016FY2025

Free cash flow

$1.6m

FY2016FY2025

Shareholders' equity

$19.0m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$31.5m$25.8m$26.2m$28.2m$21.3m$17.3m$17.4m$10.4m$1.1m$10,311
Gross profit$12.5m$9.9m$9.8m$10.0m$7.2m$5.9m$5.8m$3.3m$365,900−$2,848
Operating income$1.1m$863,712$460,152−$1.1m$3.9m$1.8m−$112,830$763,737−$856,304−$252,629
Net income−$189,864$1.4m−$1.1m−$835,745$1.8m$1.3m−$1.1m−$961,271−$851,609−$286,026
Diluted earnings per share-0.000.02-0.01-0.010.020.02-0.02-0.02-0.04-0.02

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$23.5m$22.4m$20.9m$23.9m$26.8m$17.5m$14.1m$12.5m$2.9m$369,393
Cash and short-term investments———$1.3m$1.7m$2.8m$1.6m$1.3m$136,820—
Total liabilities$4.4m$4.1m$2.7m$5.3m$8.3m$7.7m$7.0m$5.7m$1.1m$183,520
Debt$94,248$218,575—$4.0m$6.2m$6.0m$5.7m$4.6m$540,545$251,891
Shareholders' equity$19.0m$18.2m$18.2m$18.7m$18.5m$9.8m$7.1m$6.8m$1.8m$185,873
Shares outstanding86m86m87m83m79m66m61m54m22m14m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$1.6m$1.4m$2.2m$1.0m$2.2m$3.0m$613,802−$1.6m−$628,789−$187,796
Capital spending—−$25,000−$27,990−$71,241−$71,241−$6,719−$15,483−$19,422−$19,422—
Free cash flow$1.6m$1.4m$2.1m$949,489$2.1m$3.0m$598,319−$1.6m−$648,211−$187,796

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$9.4m$7.9m$8.1m$8.3m$8.0m$7.1m$6.6m$6.4m
Gross profit$3.8m$3.1m$3.2m$3.3m$3.2m$2.8m$2.6m$2.4m
Operating income$754,667$291,242$261,854$418,553$350,439$75,152$221,184$208,110
Net income$649,977$324,587−$53,728$426,171−$484,008−$78,299$886,268−$207,871
Diluted earnings per share0.010.00-0.000.00-0.01-0.000.01-0.00
Total assets$25.8m$23.4m$23.5m$23.6m$23.6m$23.2m$22.4m$21.0m
Debt$227,845$96,562$94,248$209,492$204,384$225,516$218,575$24,707
Shareholders' equity$19.4m$19.1m$19.0m$18.8m$18.7m$18.2m$18.2m$18.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.7%12.7%—
Operating income—-9.4%—
Net income-39.0%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin39.1%37.7%36.7%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-91.912.2-17.9-17.919.828.3-17.8-12.9-3.8-2.4
Price to sales0.60.70.70.51.62.01.11.23.167.5

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.